CYTLIMIC's Series B Round

CYTLIMIC raised a round of funding on August 09, 2019.

CYTLIMIC is a biotechnology company developing immunotherapy products for the treatment of cancer, including a cancer peptide vaccine. CYTLIMIC's products aim to activate immune systems to attack canc…

Articles about CYTLIMIC's Series B Round: